WO2002100266A1 - A dietary system: 'blood sugar predicting system' - Google Patents
A dietary system: 'blood sugar predicting system' Download PDFInfo
- Publication number
- WO2002100266A1 WO2002100266A1 PCT/ZA2001/000201 ZA0100201W WO02100266A1 WO 2002100266 A1 WO2002100266 A1 WO 2002100266A1 ZA 0100201 W ZA0100201 W ZA 0100201W WO 02100266 A1 WO02100266 A1 WO 02100266A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- user
- data
- human factor
- blood
- dietary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- THIS INVENTION relates to a dietary system. It also relates to a dietary device and to method of predicting a selected characteristic of blood of a user.
- the application of this invention to predict the blood sugar level of a person should be predominantly, but not exclusively, borne in mind.
- Diabetes is caused by a person's inability to produce insulin which maintains the person's blood sugar level relatively constant.
- a diabetic's inability to produce sufficient insulin can result in fluctuations in blood sugar level and, accordingly, insulin is injected into the body after a blood sugar test has been conducted i.e. to remedy a potentially dangerous fluctuation that has arisen. For example, if blood sugar levels have gone too high, kidney failure or the like may occur thereby shortening the diabetic's life. However, if the blood sugar level has gone too low, brain damage can result.
- a dietary system which includes storage means including a data base of reference human factors and a program for a computer operable to receive user data on the human factors and predict a selected characteristic of blood of the user dependent upon user data and measured blood characteristics thereby to generate a prediction model; and a portable dietary device connectable to the computer, the device including storage means for receiving and storing the prediction model; input means for receiving input human factor data from the user; processor means for interrogating the prediction model to generate a predicted blood characteristic dependent upon the input human factor data; and display means for displaying the predicted blood characteristic.
- a portable dietary device which includes storage means for receiving and storing a data base which includes a prediction model on a selected blood characteristic as a function of a human factor; input means for receiving input human factor data from a user; processor means for interrogating the prediction model to generate a predicted blood characteristic dependent upon the input human factor data; and display means for displaying the predicted blood characteristic.
- a method of predicting a selected characteristic of blood of a user including providing a data base which includes a prediction model on the selected characteristic as a function of a human factor; obtaining input human factor data from a user; interrogating the data base to obtain the selected characteristic as a function of the input human factor data; and displaying the selected characteristic.
- the human factor may be selected from the group consisting of food intake, activity level and stress level. It is, however, to be appreciated that any human factor which may affect the selected characteristic may be included.
- the selected characteristic is typically the blood sugar level of a user such as a diabetic.
- the method may be used to predict the blood sugar level as a function of time dependent upon past and future human factors.
- the display means may then provide a graphical prediction of the person's blood sugar level for a plurality of hours taking proposed future human factors into account.
- the diabetic may then alter or adapt his or her intended human factors e.g. eat a particular foodstuff, exercise more or less, or the like.
- the invention extends to a blood sugar prediction system including the system and method as hereinbefore described.
- Providing a data base may be iteratively generated by the user recording human factor data over a time period and, during the time period, periodically conducting an actual blood sugar analysis.
- the user may enter or identify in the device the combination of past and/or present human factors and use a conventional AccutrendTM device to obtain measured blood sugar level data.
- the program of the system may then include functionality to import the actual blood sugar analysis, which would be date and/or time stamped by the AccutrendTM device, and generate and/or update the prediction model.
- the dietary device may include a communications interface, e.g. an RS 232 interface or the like, for communicating with the computer running the program. Accordingly, when the user feeds in human factor data during configuration of the device, the device may date and time stamp the data. When the data is fed into the computer, the prediction means within the program may generate the prediction model from the measured blood sugar level data and the human factor data.
- a communications interface e.g. an RS 232 interface or the like
- the input means and display means of the device preferably operate in a menu driven fashion. Accordingly, the device may include appropriate software and the display means is typically an LCD display.
- the input means typically includes a scroll key, an enter key, and the like.
- the method may include prompting a user for selected human factor data in a menu driven fashion.
- the display may provide the following three human factors, "activity level”, “stress level”, and “food intake” which are selectable in a menu driven fashion. If the user selects "activity level” or “stress level”, the following options may be provided, “high”, “medium”, or “low”.
- the "activity level” may include the following further options, “select duration”, “select specific type", or the like.
- the "food intake” selection may allow selection of specific foodstuffs in predefined quantities.
- PCT Patent Application No. PCT/I BOO/00343 is hereby incorporated by reference.
- Figure 1 shows a schematic representation of a dietary system in accordance with the invention
- Figure 2 shows a block diagram of the system of Figure 1 ;
- Figure 3 shows a more detailed schematic diagram of the system of Figure 1 ;
- Figure 4 shows a schematic representation of functions performed by a dietary device of the system of Figure 1 in various stages of operation of the dietary device;
- Figure 5 shows a schematic diagram of functions performed by a user of the dietary device in various stages of operation of the dietary device
- ⁇ Q Figure 6 shows a schematic representation of various functions performed by a personal computer of the system of Figure 1 in various stages of operation of the dietary device
- Figure 7 shows a schematic representation of functions performed by a blood monitoring device of the system of Figure 1.
- reference numeral 10 generally indicates a dietary system in accordance with the invention.
- the system 10 includes a blood sugar monitoring device 12, a PC 14, a dietary device 16, also in accordance with the invention, and a patient or user 18.
- the user 18 is typically a diabetic and the system 10, as described in more detail below, may be used to predict a blood sugar level of the user
- the dietary device 16 includes a user interface 20 comprising an on/off button 22.1 , an enter button 22.2, a scroll button 22.3, and a back button 22.4.
- the device 16 further includes an RS232
- storage means or memory 26 in which a blood sugar prediction model (as described in more detail below) is stored, a processor 28 which defines a device manager and controls operation of the device 16, further memory 30, 32 in which stress level recorded data and activity level data, respectively, are stored; and storage means or memory 34 in which a food intake data file is stored and in which foodstuffs
- a blood sugar prediction model as described in more detail below
- processor 28 which defines a device manager and controls operation of the device 16
- further memory 30, 32 in which stress level recorded data and activity level data, respectively, are stored
- storage means or memory 34 in which a food intake data file is stored and in which foodstuffs
- the system 10 includes storage means in the form of a CD Rom or the like and a program for controlling operation of the PC 14.
- the CD Rom includes a comprehensive food data base 36, an activity data base 38, prediction means
- a management module 42 for creating and updating the prediction model
- a management module 42 for creating and updating the prediction model
- a serial port communication interface 44 for creating and updating the prediction model
- a graphical user interface 46 for creating and updating the prediction model
- the graphical user interface 46 and the user interface 20 of the device 16 allow a user to select and input selected data into the device 16 as shown by lines 48 and 50.
- the user 18 may, via the user interface 20, identify a particular stress level as shown at block 52, identify a particular physical activity at block 54, select and identify particular foodstuffs which have or are to be consumed during a given time period as shown at block 56, and via an LCD display 58 (see Figures 1 and 3) read the predicted blood sugar level as shown at block 60.
- the user interface 20 and the display 58 in combination with the processor 28 allow the user 18 selectively to feed data into the device 16 in a menu driven fashion (see Figure 3).
- the predicted blood sugar level predicted by the device 16 is shown in the form of a graph 60 (see Figure 3).
- stage 1 various data bases of the device 16 are configured by feeding in data sourced from both the dietary device 16 and the blood sugar monitoring device 12.
- the software run on the PC 14 takes the user 18 through a step-by-step process to build a personalised food data base stored in the memory 34, a physical activity data base stored in the memory 32, and a stress data base stored in the memory 30.
- data to generate the prediction model is acquired.
- the user 18 identifies and feeds in human factor data relating to stress level, physical activities during the period, food intake during the period and so on, into the device 16 via the user interface 20.
- the data is entered into the device 16 it is date and time stamped.
- the user also obtains measured values of his or her blood sugar level by 5 means of the blood sugar monitoring device 12.
- the device 12 is typically an AccutrendTM device which has an ability to record time and date stamp data as shown at block 64 form a blood sugar analysis on a sample as shown at block 66.
- the device 12 has a human interface 68 which includes a sensor and a graphical user interface and, in addition, a device manager is operable to control
- the device 12 further includes a serial connection 70 for connecting the device 12 to the PC 14 as shown by line 72.
- the human factors during the time period are identified and actual measured blood sugar levels are obtained and fed into the PC 14 which then, by means of the prediction means 40, generates a prediction model which provides a blood sugar level output as a function of
- the device 16 may then be used to predict a blood sugar level as a function of time (see graph 60 in Figure 3) dependent upon both past and future human factors.
- the human factors that have taken place during a particular time window as well as future human factors are used to predict the blood sugar level of the user 18.
- the user 18 may
- the processor 28 may then interrogate the data bases stored in the memory 26, 30, 32, 34 and predict a blood sugar level of the user 18.
- the user 18 may then inspect the graph 60 and dependant upon its form, modify his or her human
- the user 18 may then select or plan his or her diet accordingly so as to achieve a desired blood sugar level during the course of the day.
- the user 18 is a diabetic who can then plan their entire day insofar as food intake, physical activity or the like is concerned, so as to achieve a relatively flat blood sugar level graph.
- the device 12 may be used to randomly monitor the blood sugar level c and, if necessary, the procedures followed in stage 1 may be repeated.
- system instructions are included in the CD Rom provided with the system 10.
- the instructions may include :
- the instructions may be as follows :
- the system instructions for stage 3 may be as follows :
- the dietary device 16 obtains configured data files from the PC 0 14 as shown by block 74 whereafter the memory 34, 32 and 30 are updated as shown in blocks 76, 78, 80, respectively.
- the dietary device 16 is used to record various human factors taking place during a given time period. In particular, the device 16 is used to record the various foodstuffs which have been eaten as shown at block 82, determine what physical actions have been done as 5 shown at block 84, and record the particular stress levels experienced by the user 18 as shown at block 86.
- the memory 34, 32, 30 is updated with relevant data as shown in blocks 88, 90, 92. This process is repeated iteratively until enough data has been accumulated, whereafter the data is downloaded into the PC 14 as shown at block 94.
- the dietary device 16 is used to predict a blood sugar level of the user 18. Accordingly, as shown in Figure 4, the user 18 identifies relevant foodstuffs which are to be eaten as shown at block 96, identifies particular activities that are to take place as shown at block 98, and selects particular stress levels s shown at block 100.
- the processor 28 then processes the information in accordance with the prediction model as shown at block 102, and provides a graphical 5 representation of the predicted blood sugar level of the user 18 (see block 104) over a given time period (see graph 60 in Figure 3). If the user 18 is satisfied that the graph 60 is suitable, then the device 16 may then be used at a later date to update the human factors.
- the steps in stage 3 may be iteratively repeated to obtain a modified or new 0 predicted blood sugar level.
- the user 18 may alter the nature and quantity of the food intake so as to change the predicted blood sugar level content.
- PCT Patent Application No. PCT/I BOO/00343 in the name of Mathews, Edward Henry and Mathews, Cornelia entitled "A dietary system” is hereby incorporated by reference.
- stage 1 during which data is accumulated to generate the prediction model, the user 18 selects certain foodstuffs for a diet as shown at block 106, chooses or identifies various physical activities which are to take place during a given period, as shown at block 108, and the 0 user 18 identifies or chooses various stress levels using the user interface 20 as shown at block 110.
- stage 1 during which data is accumulated to generate the prediction model, the user 18 selects certain foodstuffs for a diet as shown at block 106, chooses or identifies various physical activities which are to take place during a given period, as shown at block 108, and the 0 user 18 identifies or chooses various stress levels using the user interface 20 as shown at block 110.
- This process is repeated iteratively and, when the user 18 is satisfied with the selection, the relevant data files from the PC 14 are uploaded into the dietary device 16 as shown at block 112.
- the user selects in blocks 106, 108, 110 data from predefined data which is provided on the CD Rom provided with the 5 system
- the user 18, by means of the user interface 20, identifies the foodstuff intake as shown at block 114, or feeds in particular physical activities which have been performed (as shown at block 116) into the dietary device as shown at blocks 118, 120. Further, the dietary device 16 ⁇ is updated by the user to identify various stress levels (see block 122) which the user 18 has been exposed to. As a result of the aforementioned human factors, the blood sugar level of the person 18 changes as shown at block 124 and the blood sugar monitoring device 12 is used to obtain a measured reading of the blood sugar level of the user 18 as shown at block 126. Thereafter, data from both the blood sugar monitoring device 12 5 and the dietary device 16 is fed into the PC 14 as shown at block 128.
- the dietary device 16 is used to predict the user 18's blood sugar level.
- the user 18 enters in planned food intake (see block 130), planned physical activities (see block 132), and estimated stress levels (see block 134) into the dietary device 16 via the user interface 0 20.
- the device 16 is thus updated with expected activities or human factors as shown at block 136 and the processor 28 provides a predicted blood sugar level output as shown at block 138. If the user 18 is not satisfied with the predicted blood sugar level output, the planned food intake, physical activities, stress levels (as shown in blocks 130, 132 and 134) may be adjusted until an acceptable graph 60 is produced. Thereafter, the user 12 would then eat the planned food as shown at block 140, do the planned physical activities 142, or try to maintain the stress level as shown at block 144.
- the blood sugar monitoring device 12 may be a conventional AccutrendTM device which obtains a measured blood sugar level as shown at block 146 (see Figure 7), which updates a recorded data file as shown at block 148 and, if sufficient data is provided, the data is downloaded into the PC 14 as shown at block 150. If sufficient measured data is not provided, the process is repeated iteratively as shown by line 152.
- stage 1 operation of the PC 14 in the various stages of operation of the system 10 is provided.
- the user 18 chooses the popular foods as shown in block 154 in an iterative manner as shown by line 156 whereafter, particular activities from a master data base are chosen in a similar fashion as shown at block 158.
- the data bases are uploaded in the dietary device 16 as shown at block 160.
- stage 2 the data is uploaded from the blood sugar monitoring device 12 and from the dietary device 16 as shown at blocks 162, 164, respectively, whereafter the prediction means generates a suitable prediction model based on the input data as shown at block 166.
- the PC 14 then uploads the prediction model into the dietary device 16 as shown at block 168.
- the PC 14 may be used to reconfigure the human factors as shown at block 170, and update the data in the device 16 as shown at block 172.
- the invention provides a relatively simple dietary system 10 including a dietary device 16 which allows a diabetic to predict blood sugar levels as a function of human factors. Accordingly, the diabetic may plan physical activity, foodstuff intake, or the like, so that an acceptable blood sugar level over a period of time is achieved. Accordingly, the likelihood of potentially dangerous fluctuations in blood sugar levels may be reduced. Further, as the user may plan his or her diet and activity level, the amount of injected insulin required by the user can be reduced thereby increasing the life expectancy of the user.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200002972 | 2000-06-13 | ||
ZA2000/2972 | 2001-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002100266A1 true WO2002100266A1 (en) | 2002-12-19 |
Family
ID=25588794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ZA2001/000201 WO2002100266A1 (en) | 2000-06-13 | 2001-12-13 | A dietary system: 'blood sugar predicting system' |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2002100266A1 (en) |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1677226A1 (en) * | 2005-01-04 | 2006-07-05 | Giacomo Vespasiani | Method and system for the management of data for a patient-controlled insulin therapy |
EP1711791A2 (en) * | 2003-12-09 | 2006-10-18 | DexCom, Inc. | Signal processing for continuous analyte sensor |
WO2007065285A2 (en) * | 2005-12-08 | 2007-06-14 | F. Hoffmann-La Roche Ag | System and method for determining drug administration information |
EP1859731A1 (en) * | 2006-05-24 | 2007-11-28 | Sysmex Corporation | Biological response prediction system, method for predicting biological response and computer program product |
US8843187B2 (en) | 2003-08-22 | 2014-09-23 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8840553B2 (en) | 1998-04-30 | 2014-09-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8858434B2 (en) | 2004-07-13 | 2014-10-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8882741B2 (en) | 2004-02-26 | 2014-11-11 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US8915849B2 (en) | 2003-08-01 | 2014-12-23 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8915850B2 (en) | 2005-11-01 | 2014-12-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8920319B2 (en) | 2005-11-01 | 2014-12-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8986209B2 (en) | 2003-08-01 | 2015-03-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9011332B2 (en) | 2001-01-02 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9020572B2 (en) | 2008-02-21 | 2015-04-28 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US9055901B2 (en) | 2004-07-13 | 2015-06-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078607B2 (en) | 2005-11-01 | 2015-07-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078608B2 (en) | 2005-03-10 | 2015-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9149233B2 (en) | 2007-12-17 | 2015-10-06 | Dexcom, Inc. | Systems and methods for processing sensor data |
WO2015166489A2 (en) | 2014-04-28 | 2015-11-05 | Yeda Research And Development Co. Ltd. | Method and apparatus for predicting response to food |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9446194B2 (en) | 2009-03-27 | 2016-09-20 | Dexcom, Inc. | Methods and systems for promoting glucose management |
US9451908B2 (en) | 2006-10-04 | 2016-09-27 | Dexcom, Inc. | Analyte sensor |
US9538946B2 (en) | 2003-11-19 | 2017-01-10 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US9717449B2 (en) | 2007-10-25 | 2017-08-01 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9741139B2 (en) | 2007-06-08 | 2017-08-22 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US9775543B2 (en) | 2004-07-13 | 2017-10-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9895089B2 (en) | 2003-08-01 | 2018-02-20 | Dexcom, Inc. | System and methods for processing analyte sensor data |
WO2019060991A1 (en) * | 2017-09-26 | 2019-04-04 | Bio-Conscious Technologies Inc. | Physiological property forecasting |
US10478108B2 (en) | 1998-04-30 | 2019-11-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10602968B2 (en) | 2008-03-25 | 2020-03-31 | Dexcom, Inc. | Analyte sensor |
US10653835B2 (en) | 2007-10-09 | 2020-05-19 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US10966609B2 (en) | 2004-02-26 | 2021-04-06 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US10980461B2 (en) | 2008-11-07 | 2021-04-20 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US11000215B1 (en) | 2003-12-05 | 2021-05-11 | Dexcom, Inc. | Analyte sensor |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11350862B2 (en) | 2017-10-24 | 2022-06-07 | Dexcom, Inc. | Pre-connected analyte sensors |
US11382539B2 (en) | 2006-10-04 | 2022-07-12 | Dexcom, Inc. | Analyte sensor |
US11399745B2 (en) | 2006-10-04 | 2022-08-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US11432772B2 (en) | 2006-08-02 | 2022-09-06 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US11559260B2 (en) | 2003-08-22 | 2023-01-24 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4731726A (en) * | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
US5822715A (en) * | 1997-01-10 | 1998-10-13 | Health Hero Network | Diabetes management system and method for controlling blood glucose |
JPH1156822A (en) * | 1997-08-19 | 1999-03-02 | Omron Corp | Blood sugar measuring instrument |
US5971922A (en) * | 1998-04-07 | 1999-10-26 | Meidensha Electric Mfg Co Ltd | System and method for predicting blood glucose level |
WO2000058851A1 (en) | 1999-03-26 | 2000-10-05 | Edward Henry Mathews | A dietary system |
-
2001
- 2001-12-13 WO PCT/ZA2001/000201 patent/WO2002100266A1/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4731726A (en) * | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
US5822715A (en) * | 1997-01-10 | 1998-10-13 | Health Hero Network | Diabetes management system and method for controlling blood glucose |
US5956501A (en) * | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
JPH1156822A (en) * | 1997-08-19 | 1999-03-02 | Omron Corp | Blood sugar measuring instrument |
US5971922A (en) * | 1998-04-07 | 1999-10-26 | Meidensha Electric Mfg Co Ltd | System and method for predicting blood glucose level |
WO2000058851A1 (en) | 1999-03-26 | 2000-10-05 | Edward Henry Mathews | A dietary system |
Non-Patent Citations (1)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 08 30 June 1999 (1999-06-30) * |
Cited By (166)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9066694B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10478108B2 (en) | 1998-04-30 | 2019-11-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011331B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9014773B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9042953B2 (en) | 1998-04-30 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326714B2 (en) | 1998-04-30 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066697B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9072477B2 (en) | 1998-04-30 | 2015-07-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8840553B2 (en) | 1998-04-30 | 2014-09-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8880137B2 (en) | 1998-04-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9498159B2 (en) | 2001-01-02 | 2016-11-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011332B2 (en) | 2001-01-02 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9610034B2 (en) | 2001-01-02 | 2017-04-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8915849B2 (en) | 2003-08-01 | 2014-12-23 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8986209B2 (en) | 2003-08-01 | 2015-03-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9895089B2 (en) | 2003-08-01 | 2018-02-20 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US10786185B2 (en) | 2003-08-01 | 2020-09-29 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US9649069B2 (en) | 2003-08-22 | 2017-05-16 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9420968B2 (en) | 2003-08-22 | 2016-08-23 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US11559260B2 (en) | 2003-08-22 | 2023-01-24 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US9750460B2 (en) | 2003-08-22 | 2017-09-05 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9724045B1 (en) | 2003-08-22 | 2017-08-08 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9585607B2 (en) | 2003-08-22 | 2017-03-07 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US11589823B2 (en) | 2003-08-22 | 2023-02-28 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9510782B2 (en) | 2003-08-22 | 2016-12-06 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9149219B2 (en) | 2003-08-22 | 2015-10-06 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9427183B2 (en) | 2003-08-22 | 2016-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8843187B2 (en) | 2003-08-22 | 2014-09-23 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US11564602B2 (en) | 2003-11-19 | 2023-01-31 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US9538946B2 (en) | 2003-11-19 | 2017-01-10 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US11000215B1 (en) | 2003-12-05 | 2021-05-11 | Dexcom, Inc. | Analyte sensor |
US11020031B1 (en) | 2003-12-05 | 2021-06-01 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US10898113B2 (en) | 2003-12-09 | 2021-01-26 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
EP2316331B1 (en) | 2003-12-09 | 2016-06-29 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US9498155B2 (en) | 2003-12-09 | 2016-11-22 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US11638541B2 (en) | 2003-12-09 | 2023-05-02 | Dexconi, Inc. | Signal processing for continuous analyte sensor |
US9420965B2 (en) | 2003-12-09 | 2016-08-23 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
EP1711791A2 (en) * | 2003-12-09 | 2006-10-18 | DexCom, Inc. | Signal processing for continuous analyte sensor |
US9192328B2 (en) | 2003-12-09 | 2015-11-24 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
EP1711791A4 (en) * | 2003-12-09 | 2008-02-27 | Dexcom Inc | Signal processing for continuous analyte sensor |
US9107623B2 (en) | 2003-12-09 | 2015-08-18 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
EP2316331A1 (en) * | 2003-12-09 | 2011-05-04 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US9750441B2 (en) | 2003-12-09 | 2017-09-05 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US9364173B2 (en) | 2003-12-09 | 2016-06-14 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US9351668B2 (en) | 2003-12-09 | 2016-05-31 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US10835672B2 (en) | 2004-02-26 | 2020-11-17 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8920401B2 (en) | 2004-02-26 | 2014-12-30 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US8926585B2 (en) | 2004-02-26 | 2015-01-06 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US10966609B2 (en) | 2004-02-26 | 2021-04-06 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US9155843B2 (en) | 2004-02-26 | 2015-10-13 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US9050413B2 (en) | 2004-02-26 | 2015-06-09 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US11246990B2 (en) | 2004-02-26 | 2022-02-15 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US8882741B2 (en) | 2004-02-26 | 2014-11-11 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US10918313B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US11064917B2 (en) | 2004-07-13 | 2021-07-20 | Dexcom, Inc. | Analyte sensor |
US8858434B2 (en) | 2004-07-13 | 2014-10-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9060742B2 (en) | 2004-07-13 | 2015-06-23 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9055901B2 (en) | 2004-07-13 | 2015-06-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10993641B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10918314B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10524703B2 (en) | 2004-07-13 | 2020-01-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10993642B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US11026605B1 (en) | 2004-07-13 | 2021-06-08 | Dexcom, Inc. | Analyte sensor |
US10827956B2 (en) | 2004-07-13 | 2020-11-10 | Dexcom, Inc. | Analyte sensor |
US10918315B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10932700B2 (en) | 2004-07-13 | 2021-03-02 | Dexcom, Inc. | Analyte sensor |
US9775543B2 (en) | 2004-07-13 | 2017-10-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9801572B2 (en) | 2004-07-13 | 2017-10-31 | Dexcom, Inc. | Transcutaneous analyte sensor |
US11045120B2 (en) | 2004-07-13 | 2021-06-29 | Dexcom, Inc. | Analyte sensor |
US10813576B2 (en) | 2004-07-13 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US10799159B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10799158B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10980452B2 (en) | 2004-07-13 | 2021-04-20 | Dexcom, Inc. | Analyte sensor |
US10722152B2 (en) | 2004-07-13 | 2020-07-28 | Dexcom, Inc. | Analyte sensor |
US10709363B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10709362B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
EP2194475A1 (en) * | 2005-01-04 | 2010-06-09 | Lifescan, Inc. | Method and system for the management of data for a patient-controlled insulin therapy |
EP1677226A1 (en) * | 2005-01-04 | 2006-07-05 | Giacomo Vespasiani | Method and system for the management of data for a patient-controlled insulin therapy |
US10716498B2 (en) | 2005-03-10 | 2020-07-21 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11051726B2 (en) | 2005-03-10 | 2021-07-06 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918317B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11000213B2 (en) | 2005-03-10 | 2021-05-11 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10898114B2 (en) | 2005-03-10 | 2021-01-26 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10856787B2 (en) | 2005-03-10 | 2020-12-08 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10617336B2 (en) | 2005-03-10 | 2020-04-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918316B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9078608B2 (en) | 2005-03-10 | 2015-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10709364B2 (en) | 2005-03-10 | 2020-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10925524B2 (en) | 2005-03-10 | 2021-02-23 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918318B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9314196B2 (en) | 2005-03-10 | 2016-04-19 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9918668B2 (en) | 2005-03-10 | 2018-03-20 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9220449B2 (en) | 2005-03-10 | 2015-12-29 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10743801B2 (en) | 2005-03-10 | 2020-08-18 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US8920319B2 (en) | 2005-11-01 | 2014-12-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10952652B2 (en) | 2005-11-01 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11911151B1 (en) | 2005-11-01 | 2024-02-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11272867B2 (en) | 2005-11-01 | 2022-03-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10201301B2 (en) | 2005-11-01 | 2019-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326716B2 (en) | 2005-11-01 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11363975B2 (en) | 2005-11-01 | 2022-06-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10231654B2 (en) | 2005-11-01 | 2019-03-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078607B2 (en) | 2005-11-01 | 2015-07-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11103165B2 (en) | 2005-11-01 | 2021-08-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8915850B2 (en) | 2005-11-01 | 2014-12-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11399748B2 (en) | 2005-11-01 | 2022-08-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
WO2007065285A3 (en) * | 2005-12-08 | 2007-08-02 | Hoffmann La Roche | System and method for determining drug administration information |
WO2007065285A2 (en) * | 2005-12-08 | 2007-06-14 | F. Hoffmann-La Roche Ag | System and method for determining drug administration information |
US7941200B2 (en) | 2005-12-08 | 2011-05-10 | Roche Diagnostics Operations, Inc. | System and method for determining drug administration information |
EP1859731A1 (en) * | 2006-05-24 | 2007-11-28 | Sysmex Corporation | Biological response prediction system, method for predicting biological response and computer program product |
US11432772B2 (en) | 2006-08-02 | 2022-09-06 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US10349873B2 (en) | 2006-10-04 | 2019-07-16 | Dexcom, Inc. | Analyte sensor |
US9451908B2 (en) | 2006-10-04 | 2016-09-27 | Dexcom, Inc. | Analyte sensor |
US11399745B2 (en) | 2006-10-04 | 2022-08-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US11382539B2 (en) | 2006-10-04 | 2022-07-12 | Dexcom, Inc. | Analyte sensor |
US10403012B2 (en) | 2007-06-08 | 2019-09-03 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US9741139B2 (en) | 2007-06-08 | 2017-08-22 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US11373347B2 (en) | 2007-06-08 | 2022-06-28 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US11160926B1 (en) | 2007-10-09 | 2021-11-02 | Dexcom, Inc. | Pre-connected analyte sensors |
US11744943B2 (en) | 2007-10-09 | 2023-09-05 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US10653835B2 (en) | 2007-10-09 | 2020-05-19 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US10182751B2 (en) | 2007-10-25 | 2019-01-22 | Dexcom, Inc. | Systems and methods for processing sensor data |
US11272869B2 (en) | 2007-10-25 | 2022-03-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9717449B2 (en) | 2007-10-25 | 2017-08-01 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9149233B2 (en) | 2007-12-17 | 2015-10-06 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9149234B2 (en) | 2007-12-17 | 2015-10-06 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9901307B2 (en) | 2007-12-17 | 2018-02-27 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9339238B2 (en) | 2007-12-17 | 2016-05-17 | Dexcom, Inc. | Systems and methods for processing sensor data |
US10827980B2 (en) | 2007-12-17 | 2020-11-10 | Dexcom, Inc. | Systems and methods for processing sensor data |
US10506982B2 (en) | 2007-12-17 | 2019-12-17 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9839395B2 (en) | 2007-12-17 | 2017-12-12 | Dexcom, Inc. | Systems and methods for processing sensor data |
US11342058B2 (en) | 2007-12-17 | 2022-05-24 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9143569B2 (en) | 2008-02-21 | 2015-09-22 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US9020572B2 (en) | 2008-02-21 | 2015-04-28 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US11102306B2 (en) | 2008-02-21 | 2021-08-24 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US10602968B2 (en) | 2008-03-25 | 2020-03-31 | Dexcom, Inc. | Analyte sensor |
US11896374B2 (en) | 2008-03-25 | 2024-02-13 | Dexcom, Inc. | Analyte sensor |
US10980461B2 (en) | 2008-11-07 | 2021-04-20 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US10610642B2 (en) | 2009-03-27 | 2020-04-07 | Dexcom, Inc. | Methods and systems for promoting glucose management |
US10537678B2 (en) | 2009-03-27 | 2020-01-21 | Dexcom, Inc. | Methods and systems for promoting glucose management |
US10675405B2 (en) | 2009-03-27 | 2020-06-09 | Dexcom, Inc. | Methods and systems for simulating glucose response to simulated actions |
US9446194B2 (en) | 2009-03-27 | 2016-09-20 | Dexcom, Inc. | Methods and systems for promoting glucose management |
US11610681B2 (en) | 2014-04-28 | 2023-03-21 | Yeda Research And Development Co. Ltd. | Method and apparatus for predicting response to food |
US10361003B2 (en) | 2014-04-28 | 2019-07-23 | Yeda Research And Development Co. Ltd. | Method and apparatus for predicting response to food |
WO2015166489A2 (en) | 2014-04-28 | 2015-11-05 | Yeda Research And Development Co. Ltd. | Method and apparatus for predicting response to food |
US10923230B2 (en) | 2014-04-28 | 2021-02-16 | Yeda Research And Development Co. Ltd. | Method and apparatus for predicting response to food |
GB2581081B (en) * | 2017-09-26 | 2022-08-17 | Bio Conscious Tech Inc | Physiological property forecasting |
WO2019060991A1 (en) * | 2017-09-26 | 2019-04-04 | Bio-Conscious Technologies Inc. | Physiological property forecasting |
GB2581081A (en) * | 2017-09-26 | 2020-08-05 | Bio Conscious Tech Inc | Physiological property forecasting |
US11382540B2 (en) | 2017-10-24 | 2022-07-12 | Dexcom, Inc. | Pre-connected analyte sensors |
US11706876B2 (en) | 2017-10-24 | 2023-07-18 | Dexcom, Inc. | Pre-connected analyte sensors |
US11350862B2 (en) | 2017-10-24 | 2022-06-07 | Dexcom, Inc. | Pre-connected analyte sensors |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11943876B2 (en) | 2017-10-24 | 2024-03-26 | Dexcom, Inc. | Pre-connected analyte sensors |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002100266A1 (en) | A dietary system: 'blood sugar predicting system' | |
EP1972270B1 (en) | Method and glucose monitoring system for monitoring individual metabolic response | |
US20180226150A1 (en) | Systems, devices, and methods for episode detection and evaluation with visit guides, action plans and/or scheduling interfaces | |
US7912674B2 (en) | Method for processing a chronological sequence of measurements of a time dependent parameter | |
US9330237B2 (en) | Pattern recognition and filtering in a therapy management system | |
CA2745169C (en) | Diabetes therapy management system | |
US20110124996A1 (en) | Diabetes health management systems and methods | |
US7751907B2 (en) | Expert system for insulin pump therapy | |
CN110191731A (en) | Infusion system and relevant personalized method of adjustment | |
US20120059673A1 (en) | Flexible glucose analysis using varying time report deltas and configurable glucose target ranges | |
EP2043507B1 (en) | Mobile apparatus, method and system for processing blood sugar affecting factors | |
US20100161346A1 (en) | Systems and Methods for Providing Bolus Dosage Recommendations | |
US20050187749A1 (en) | Method, system, and computer program for performing carbohydrate/insulin calculation based upon food weight | |
CN103562921A (en) | Location enabled food database | |
US20060095225A1 (en) | Method and computer program for pattern analysis and reporting of chronic disease state management data | |
JP2010528703A (en) | Insulin pump based on expert system | |
WO2009035477A1 (en) | System and method for medical evaluation and monitoring | |
WO2008048452A2 (en) | Therapy management system | |
JP6948095B1 (en) | Programs, methods, and systems | |
US20100138453A1 (en) | System and method for generating a personalized diabetes management tool for diabetes mellitus | |
CN106068095A (en) | Blood glucose meter and using method | |
CA2938541C (en) | Diabetes therapy management system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |